Human Human DCLK3 partial (162-632) Recombinant Protein
Reference:
Description of Human Human DCLK3 partial (162-632) Recombinant Protein
Description of Human Human DCLK3 partial (162-632) Recombinant Protein
Product name | Human Human DCLK3 partial (162-632) Recombinant Protein |
---|
Origin species | Homo sapiens (Human) |
---|
Expression system | Procaryotic expression |
---|
Molecular weight | 54.83kDa |
---|
Purity estimated | 30% |
---|
Buffer | PBS, pH 7.5 |
---|
Form | Frozen |
---|
Delivery condition | Dry Ice |
---|
Storage condition | 4°C for short term (1 week), -20°C or -80°C for long term (avoid freezing/thawing cycles; addition of 20-40% glycerol improves cryoprotection) |
---|
Brand | ProteoGenix |
---|
Host species | Escherichia coli (E.coli) |
---|
Fragment Type | Partial |
---|
Aliases /Synonyms | Human DCLK3 partial (162-632), doublecortin-like kinase 3, Serine/threonine-protein kinase DCLK3 ou Doublecortin domain-containing protein 3C ou Doublecortin-like and CAM kinase-like 3 ou Doublecortin-like kinase 3 |
---|
Reference | PX-P2075 |
---|
Note | For research use only |
---|
Product name | Human Human DCLK3 partial (162-632) Recombinant Protein |
---|
Origin species | Homo sapiens (Human) |
---|
Expression system | Procaryotic expression |
---|
Molecular weight | 54.83kDa |
---|
Purity estimated | 30% |
---|
Buffer | PBS, pH 7.5 |
---|
Form | Frozen |
---|
Delivery condition | Dry Ice |
---|
Storage condition | 4°C for short term (1 week), -20°C or -80°C for long term (avoid freezing/thawing cycles; addition of 20-40% glycerol improves cryoprotection) |
---|
Brand | ProteoGenix |
---|
Host species | Escherichia coli (E.coli) |
---|
Fragment Type | Partial |
---|
Aliases /Synonyms | Human DCLK3 partial (162-632), doublecortin-like kinase 3, Serine/threonine-protein kinase DCLK3 ou Doublecortin domain-containing protein 3C ou Doublecortin-like and CAM kinase-like 3 ou Doublecortin-like kinase 3 |
---|
Reference | PX-P2075 |
---|
Note | For research use only |
---|
Reviews
There are no reviews yet.